MX384877B - Composiciones de éster de colina de ácido lipoico y métodos de uso. - Google Patents
Composiciones de éster de colina de ácido lipoico y métodos de uso.Info
- Publication number
- MX384877B MX384877B MX2016011290A MX2016011290A MX384877B MX 384877 B MX384877 B MX 384877B MX 2016011290 A MX2016011290 A MX 2016011290A MX 2016011290 A MX2016011290 A MX 2016011290A MX 384877 B MX384877 B MX 384877B
- Authority
- MX
- Mexico
- Prior art keywords
- lipoic acid
- choline ester
- acid choline
- methods
- aqueous
- Prior art date
Links
- -1 LIPOIC ACID CHOLINE ESTER Chemical class 0.000 title abstract 3
- 229960001231 choline Drugs 0.000 title abstract 3
- 235000019136 lipoic acid Nutrition 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 229960002663 thioctic acid Drugs 0.000 title abstract 3
- 239000007864 aqueous solution Substances 0.000 abstract 2
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se relaciona con composiciones farmacéuticas que comprenden una cantidad terapéuticamente efectiva de éster de colina del ácido lipoico o derivados del mismo y un excipiente no acuoso mezclado en una solución acuosa. También se proporcionan en la presente composiciones no acuosas preparadas mezclando la cantidad terapéuticamente efectiva de éster de colina del ácido lipoico y el excipiente no acuoso. Las composiciones no acuosas además pueden mezclarse con la solución acuosa.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461947378P | 2014-03-03 | 2014-03-03 | |
| PCT/US2015/018505 WO2015134510A1 (en) | 2014-03-03 | 2015-03-03 | Lipoic acid choline ester compositions and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2016011290A MX2016011290A (es) | 2017-04-27 |
| MX384877B true MX384877B (es) | 2025-03-14 |
Family
ID=54055796
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016011290A MX384877B (es) | 2014-03-03 | 2015-03-03 | Composiciones de éster de colina de ácido lipoico y métodos de uso. |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20160354340A1 (es) |
| EP (1) | EP3113613A4 (es) |
| JP (1) | JP6526066B2 (es) |
| KR (1) | KR20160145558A (es) |
| CN (2) | CN112641720A (es) |
| AU (2) | AU2015227307A1 (es) |
| BR (1) | BR112016020181A8 (es) |
| CA (1) | CA2941518A1 (es) |
| IL (1) | IL247529B (es) |
| MX (1) | MX384877B (es) |
| RU (1) | RU2735790C2 (es) |
| WO (1) | WO2015134510A1 (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2904580T3 (es) * | 2015-09-24 | 2022-04-05 | Novartis Ag | Composiciones de éster de colina del ácido lipoico y métodos para generar formulaciones oftálmicas biocompatibles. |
| JOP20190057A1 (ar) * | 2016-09-23 | 2019-03-24 | Encore Vision Inc | تركيبات استر كولين حمض الليبويك وطرق تثبيتها إلى منتجات عقار ذات صلة دوائية |
| US10052343B1 (en) | 2017-02-03 | 2018-08-21 | Gene Signal International Sa | Sterile formulation comprising a stable phosphorothioate oligonucleotide |
| CN107089967A (zh) * | 2017-05-12 | 2017-08-25 | 苏州富士莱医药股份有限公司 | 一种r‑硫辛酸胆碱酯卤化物的制备方法 |
| CN106967044B (zh) * | 2017-05-12 | 2019-02-22 | 苏州富士莱医药股份有限公司 | 制备r-硫辛酸胆碱酯卤化物的方法 |
| CN109394745A (zh) * | 2017-08-17 | 2019-03-01 | 博瑞生物医药(苏州)股份有限公司 | 一种包含左旋肉碱和β-羟基丁酸化合物的组合物 |
| JPWO2020213693A1 (es) * | 2019-04-17 | 2020-10-22 | ||
| US20200383946A1 (en) * | 2019-05-07 | 2020-12-10 | Aciont Inc. | Lipoic acid formulations |
| CN113387923A (zh) | 2020-03-13 | 2021-09-14 | 诺华股份有限公司 | 硫辛酸胆碱酯盐的药物组合物及使用其的治疗方法 |
| CN113717770B (zh) * | 2020-05-25 | 2022-06-03 | 中国石油天然气股份有限公司 | 一种金属加工油 |
| GB202305212D0 (en) | 2023-04-06 | 2023-05-24 | Elixa Mediscience Ltd | Compounds |
Family Cites Families (88)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB935962A (en) | 1960-06-17 | 1963-09-04 | Fujisawa Pharmaceutical Co | Improvements in or relating to the production of 6.8-dithiooctanamides |
| US3855240A (en) | 1969-04-28 | 1974-12-17 | Exxon Research Engineering Co | Sulfur containing heterocycles |
| US4210667A (en) | 1979-04-19 | 1980-07-01 | Pfizer Inc. | Pharmaceutical preparations containing coumarin carboxylic acid derivatives |
| US4755528A (en) | 1984-12-06 | 1988-07-05 | Alcon Laboratories, Inc. | High energy ionizing protective 2,3-diamino-1,4-butanedithiol; 4,5-diamino-1,2-dithiane; and N-acyl and N-alkyl derivatives thereof, compositions and method of use therefor |
| US6030950A (en) | 1987-07-09 | 2000-02-29 | Ohlenschlaeger; Gerhard | Pharmaceutical therapeutic use of glutathione derivative |
| US5599903A (en) | 1992-04-03 | 1997-02-04 | Terrapin Technologies, Inc. | Glutathione analogs and paralog panels comprising glutathione mimics |
| FR2638970A1 (fr) | 1988-11-16 | 1990-05-18 | Corbiere Jerome | Nouvelles compositions pharmaceutiques agissant sur la presbytie et leur procede d'obtention |
| WO1993002639A1 (en) | 1991-08-06 | 1993-02-18 | Autogenesis Technologies, Inc. | Injectable collagen-based compositions for making intraocular lens |
| US5466680A (en) | 1992-03-26 | 1995-11-14 | Cytologics, Inc. | Method and compositions for enhancing white blood cell functioning on a mucosal or cutaneous surface |
| US5459133A (en) | 1992-06-05 | 1995-10-17 | Telor Ophthalmic Pharmaceuticals, Inc. | Methods and products for treating presbyopia |
| AU4633793A (en) | 1992-06-10 | 1994-01-04 | Summit Technology, Inc. | Correction of presbyopia by photorefractive keratectomy |
| JPH07508751A (ja) | 1992-07-02 | 1995-09-28 | テラー・オフサルミック・ファーマシューティカルズ・インコーポレーテッド | 老視治療のための方法および生産品 |
| FI950062A7 (fi) | 1992-07-06 | 1995-01-05 | Biomira Inc | Proteiinien foroaktivaatio konjugaatiotarkoituksia varten |
| US5465737A (en) | 1992-07-15 | 1995-11-14 | Schachar; Ronald A. | Treatment of presbyopia and other eye disorders |
| US5354331A (en) | 1992-07-15 | 1994-10-11 | Schachar Ronald A | Treatment of presbyopia and other eye disorders |
| WO1994003129A1 (en) | 1992-08-07 | 1994-02-17 | Keravision Inc. | Hybrid intrastromal corneal ring |
| DE4345199C2 (de) * | 1993-05-22 | 1995-10-12 | Asta Medica Ag | Verwendung von Dihydroliponsäure zur Unterdrückung von Unverträglichkeitsreaktionen im Grenzbereich von Implantaten mit lebendem Körpergewebe |
| US5395356A (en) | 1993-06-04 | 1995-03-07 | Summit Technology, Inc. | Correction of presbyopia by photorefractive keratectomy |
| US5527774A (en) | 1993-07-12 | 1996-06-18 | Girard; Louis J. | Dislocation of cataractous lens by enzymatic zonulolysis |
| US5665770A (en) | 1993-11-05 | 1997-09-09 | Gakko Hojin Kinki Daigaku | Method for treatment of cataract with radical scavenger |
| EP0754046A1 (en) | 1994-04-04 | 1997-01-22 | FREEMAN, William R. | Use of phosphonylmethoxyalkyl nucleosides for the treatment of raised intraocular pressure |
| US6063116A (en) | 1994-10-26 | 2000-05-16 | Medarex, Inc. | Modulation of cell proliferation and wound healing |
| US6743779B1 (en) | 1994-11-29 | 2004-06-01 | Imarx Pharmaceutical Corp. | Methods for delivering compounds into a cell |
| US5624955A (en) | 1995-05-03 | 1997-04-29 | Regents Of The University Of Minnesota | Compounds that enhance the concentration of glutathione in tissues |
| US5686450A (en) | 1995-06-07 | 1997-11-11 | Alcon Laboratories, Inc. | Use of N,N'-bis(mercaptoacetyl) hydrazine derivatives as anticataract agents |
| US6007510A (en) | 1996-10-25 | 1999-12-28 | Anamed, Inc. | Implantable devices and methods for controlling the flow of fluids within the body |
| US5817630A (en) | 1997-03-18 | 1998-10-06 | Austin Nutriceutical Corporation | Glutathione antioxidant eye drops |
| IL123887A0 (en) | 1997-04-02 | 1998-10-30 | Sankyo Co | Dithiolan derivatives their use and pharmaceutical compositions containing the same |
| US5843184A (en) | 1998-01-26 | 1998-12-01 | Cionni; Robert J. | Endocapsular tension ring and method of implanting same |
| US6153647A (en) | 1998-11-12 | 2000-11-28 | My-Tech, Inc. | Method for augmenting the inotropic effects of β-adrenergic agonists using pyruvate therapy |
| US6472541B2 (en) | 1998-11-20 | 2002-10-29 | The Regents Of The University Of California | Protecting groups with increased photosensitivities |
| JP2002535247A (ja) | 1998-11-26 | 2002-10-22 | ペンタファルム アクチェンゲゼルシャフト | 輸送系複合体 |
| US6288106B1 (en) | 1999-05-25 | 2001-09-11 | Chronorx, Llc | Processes for the synthesis and use of various α-lipoic acid complexes |
| US6339102B1 (en) | 1999-06-09 | 2002-01-15 | The United States Of America As Represented By The Secretary Of The Army | Method and composition for treating and preventing retinal damage |
| JP4476435B2 (ja) * | 1999-07-22 | 2010-06-09 | 株式会社細川洋行 | 仕切部材、複室輸液容器および薬剤入り複室輸液容器の製造方法 |
| US6890896B1 (en) | 1999-11-18 | 2005-05-10 | Ceremedix, Inc. | Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| US6387945B2 (en) | 2000-04-11 | 2002-05-14 | The Regents Of The University Of California | Lipoic acid analogs |
| WO2002003863A1 (en) | 2000-07-10 | 2002-01-17 | Koninklijke Philips Electronics N.V. | Geometry matching for imaging medical apparatus |
| WO2002010151A2 (de) | 2000-08-02 | 2002-02-07 | Basf Aktiengesellschaft | Verfahren zur herstellung von liponsäure und dihydroliponsäure |
| US20050112113A1 (en) | 2000-08-16 | 2005-05-26 | Till Jonathan S. | Presbyopia treatment by lens alteration |
| US8697109B2 (en) | 2000-08-16 | 2014-04-15 | Encore Health, Llc | Caged mercaptan and seleno-mercaptan compounds and methods of using them |
| US7935332B2 (en) | 2000-08-16 | 2011-05-03 | Encore Health, Llc | Presbyopia treatment by lens alteration |
| US7914815B2 (en) | 2000-08-16 | 2011-03-29 | Encore Health, Llc | Method for delivery of pharmaceuticals for treating or preventing presbyopia |
| WO2002013863A2 (en) | 2000-08-16 | 2002-02-21 | Refocus, Llc. | Presbyopia treatment by lens alteration |
| US6923955B2 (en) | 2000-08-16 | 2005-08-02 | Newlens, Llc | Presbyopia treatment by lens alteration |
| US8647612B2 (en) | 2008-03-05 | 2014-02-11 | Encore Health, Llc | Dithiol compounds, derivatives, and treatment of presbyopia |
| US8147816B2 (en) | 2000-08-16 | 2012-04-03 | Encore Health, Llc | Presbyopia treatment by lens alteration |
| DE10045059A1 (de) | 2000-09-12 | 2002-03-21 | Basf Ag | Therapeutische Kombination von Liponsäure und Konjuensäuren zur Behandlung diabetischer Störungen |
| US6273092B1 (en) | 2000-09-22 | 2001-08-14 | Gerard M. Nolan | Methods for treating various eye disorders |
| US6703039B2 (en) | 2000-12-06 | 2004-03-09 | Bausch & Lomb Incorporated | Reversible gelling system for ocular drug delivery |
| EP1808158A3 (en) | 2001-01-19 | 2008-06-18 | Newlens, LLC | Presbyopia treatment by lens alteration |
| DE60234164D1 (de) | 2001-03-19 | 2009-12-10 | Senju Pharma Co | Neues a-liponsäurederivat und dessen verwendung |
| EP1521735A2 (en) | 2001-05-25 | 2005-04-13 | Ceremedix, Inc | Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals |
| FR2832637B1 (fr) | 2001-06-07 | 2004-07-30 | Lefaix Marie Therese Droy | Utilisation d'un antioxydant pour la fabrication d'un medicament destine au traitement des affections oculaires de surface |
| ITMI20011232A1 (it) | 2001-06-12 | 2002-12-12 | St Microelectronics Srl | Metodo di riprogrammazione successiva ad una operazione di cancellazione di una matrice di celle di memoria non volatile, in particolare di |
| AU2002254546A1 (en) | 2002-04-03 | 2003-10-20 | Mitchell A. Avery | Lipoic acid analogs useful as provitamins and antioxidants |
| US20050137124A1 (en) | 2002-08-09 | 2005-06-23 | Vitreo-Retinal Technologies, Inc. A California Corporation | Agents for intravitreal administration to treat or prevent disorders of the eye |
| CN100367949C (zh) | 2002-09-13 | 2008-02-13 | 有限会社绪方研究 | 黑色素消除制剂 |
| US7795203B2 (en) * | 2002-09-30 | 2010-09-14 | Babizhayev Mark A | Method for topical treatment of eye disease and composition and device for said treatment |
| US20060177430A1 (en) | 2002-12-20 | 2006-08-10 | Chakshu Research Inc | Treatment of ocular disorders with ophthalmic formulations containing methylsulfonylmethane as a transport enhancer |
| US7941211B2 (en) | 2003-11-17 | 2011-05-10 | Zeavision, Llc. | Preloading with macular pigment to improve photodynamic treatment of retinal vascular disorders |
| AU2004293477A1 (en) | 2003-11-25 | 2005-06-09 | University Of Rochester | Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof |
| US7718697B2 (en) | 2003-12-17 | 2010-05-18 | Alcon, Inc. | Method for treating glaucoma comprising administering α-lipoic acid |
| GB0404693D0 (en) | 2004-03-02 | 2004-04-07 | Univ London | Pharmaceutical preparations for the treatment of ocular surface and other disorders |
| FR2869531B1 (fr) | 2004-04-30 | 2006-07-14 | Optis France Sa Sa | Dispositif de iontophorese oculaire diminuant les irritations |
| US7264279B2 (en) | 2004-07-08 | 2007-09-04 | Fab-Tech, Inc. | Segmented conduit having a monolithic lining |
| US20080038316A1 (en) | 2004-10-01 | 2008-02-14 | Wong Vernon G | Conveniently implantable sustained release drug compositions |
| US20060188492A1 (en) | 2005-01-13 | 2006-08-24 | Chronorx Llc, An Alaska Limited Liability Company | Topical management of ocular and periocular conditions |
| US20060275278A1 (en) * | 2005-06-02 | 2006-12-07 | Choy Camus K M | Method and ophthalmic formulation for eye protection or treatment |
| EP1904108B1 (en) | 2005-07-15 | 2011-11-30 | Chakshu Research, Inc. | Ophthalmological formulation comprising methylsulfonylmethane and ciprofloxacin |
| US20070055070A1 (en) | 2005-09-07 | 2007-03-08 | Lawrence Lowell J | Novel esters of lipoic acid |
| US20070207116A1 (en) * | 2006-03-01 | 2007-09-06 | Brown David C | Antioxidant compositions for the eye |
| CN101522658A (zh) | 2006-06-16 | 2009-09-02 | 因迪基恩药物公司 | 作为抗糖尿病药用于控制糖尿病高血糖症和糖尿病并发症的二甲双胍r-(+)硫辛酸盐 |
| EP2099947A1 (de) * | 2006-12-08 | 2009-09-16 | Sachtleben Chemie GmbH | Titanhaltige formkörper |
| DE102006062599B4 (de) | 2006-12-29 | 2018-03-08 | Endress + Hauser Gmbh + Co. Kg | Opto-elektronische Vorrichtung zur Übertragung eines elektrischen Signals und deren Verwendung |
| ES2732293T3 (es) | 2007-02-22 | 2019-11-21 | Childrens Hospital & Res Center At Oakland | Formulaciones de ácidos grasos y métodos para el uso de las mismas |
| EP2125775A4 (en) | 2007-03-01 | 2011-07-13 | Cedars Sinai Medical Center | ANTIOXIDATION POLYMERS WITH [1,2] -DITHIOLANTEILES AND THEIR USE |
| UA86441C2 (ru) | 2007-03-30 | 2009-04-27 | Акционерное Общество Открытого Типа "Галичфарм" | (2-гидроксиэтил)триметиламмония тиоктат (холина тиоктат), имеющий гепатопротекторное, гипоаммониемическое и детоксицирующее действие, способ его получения, фармацевтическая композиция на его основе |
| JP5276591B2 (ja) * | 2007-08-09 | 2013-08-28 | 千寿製薬株式会社 | ピレノキシン含有二液性点眼剤 |
| US9044439B2 (en) | 2008-03-05 | 2015-06-02 | Encore Health, Llc | Low dose lipoic and pharmaceutical compositions and methods |
| WO2009111635A2 (en) | 2008-03-05 | 2009-09-11 | Encore Health, Llc | Dithiol compounds, derivatives, and uses therefor |
| ES2579173T3 (es) | 2009-06-15 | 2016-08-05 | Encore Health, Llc | Ésteres de colina para tratar presbicia y cataratas |
| EP3069612A3 (en) * | 2009-06-15 | 2016-10-19 | Encore Health, LLC | Dithiol compounds, derivatives, and uses therefor |
| DE102010009475B4 (de) * | 2010-02-26 | 2011-11-24 | F. Holzer Gmbh | Verfahren zur Herstellung eines dosierbaren applikationsfertigen Präparates |
| ES2564502T3 (es) | 2010-03-17 | 2016-03-23 | Novaliq Gmbh | Composición farmacéutica para el tratamiento de la presión intraocular aumentada |
| EP2661280B1 (en) * | 2011-01-04 | 2018-11-21 | Novaliq GmbH | O/w-emulsions comprising semifluorinated alkanes |
| PT2806886T (pt) * | 2012-01-23 | 2017-03-24 | Novaliq Gmbh | Composições de proteínas estabilizadas baseadas em alcanos semifluorados |
| HK1204988A1 (en) * | 2012-02-22 | 2015-12-11 | Stealth Peptides International, Inc. | Methods and compositions for preventing or treating ophthalmic conditions |
-
2015
- 2015-03-03 EP EP15758583.7A patent/EP3113613A4/en not_active Withdrawn
- 2015-03-03 CA CA2941518A patent/CA2941518A1/en not_active Abandoned
- 2015-03-03 BR BR112016020181A patent/BR112016020181A8/pt not_active IP Right Cessation
- 2015-03-03 MX MX2016011290A patent/MX384877B/es unknown
- 2015-03-03 RU RU2016137784A patent/RU2735790C2/ru active
- 2015-03-03 WO PCT/US2015/018505 patent/WO2015134510A1/en not_active Ceased
- 2015-03-03 JP JP2016573672A patent/JP6526066B2/ja not_active Expired - Fee Related
- 2015-03-03 CN CN202011555416.1A patent/CN112641720A/zh active Pending
- 2015-03-03 AU AU2015227307A patent/AU2015227307A1/en not_active Abandoned
- 2015-03-03 KR KR1020167026593A patent/KR20160145558A/ko not_active Ceased
- 2015-03-03 CN CN201580012000.6A patent/CN106455563A/zh active Pending
- 2015-03-03 US US15/118,910 patent/US20160354340A1/en not_active Abandoned
-
2016
- 2016-08-29 IL IL247529A patent/IL247529B/en active IP Right Grant
-
2019
- 2019-09-22 US US16/578,368 patent/US11426381B2/en active Active
- 2019-10-02 AU AU2019240641A patent/AU2019240641B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| IL247529A0 (en) | 2016-11-30 |
| US11426381B2 (en) | 2022-08-30 |
| US20160354340A1 (en) | 2016-12-08 |
| JP6526066B2 (ja) | 2019-06-05 |
| CN106455563A (zh) | 2017-02-22 |
| RU2016137784A3 (es) | 2018-10-18 |
| CA2941518A1 (en) | 2015-09-11 |
| JP2017511816A (ja) | 2017-04-27 |
| IL247529B (en) | 2020-10-29 |
| KR20160145558A (ko) | 2016-12-20 |
| RU2735790C2 (ru) | 2020-11-09 |
| CN112641720A (zh) | 2021-04-13 |
| EP3113613A4 (en) | 2019-03-13 |
| BR112016020181A2 (pt) | 2017-08-15 |
| WO2015134510A1 (en) | 2015-09-11 |
| AU2015227307A1 (en) | 2016-10-13 |
| BR112016020181A8 (pt) | 2021-06-29 |
| MX2016011290A (es) | 2017-04-27 |
| EP3113613A1 (en) | 2017-01-11 |
| US20200281891A1 (en) | 2020-09-10 |
| RU2016137784A (ru) | 2018-04-03 |
| AU2019240641A1 (en) | 2019-10-24 |
| AU2019240641B2 (en) | 2020-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2017011535A2 (es) | Composiciones de ácido obeticólico y métodos de uso | |
| BR112016020181A8 (pt) | composições de ácido lipoico éster colina e métodos de uso. | |
| NI201700034A (es) | Indazoles sustituidos con benzilo como inhibidores de bub1. | |
| CL2016002772A1 (es) | Composiciones de insulina de rápida acción | |
| CL2016000153A1 (es) | Derivados de pirrolamida sustituidos con glioxamida y su uso como medicamentos para el tratamiento de la hepatitis b | |
| MX2021001231A (es) | Compuestos heterociclicos y sus usos. | |
| EA201691988A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
| EP3206706A4 (en) | Stable injectable composition of pharmaceutically active agents and process for its preparation | |
| CL2014001865A1 (es) | Compuestos derivados de fosfatos; procedimiento de preparacion; composiciones farmaceuticas que los contienen y uso en el tratamiento del cancer. | |
| BR112017012406A2 (pt) | formulação com relação fixa de insulina glargina/lixisenatida | |
| WO2014153009A3 (en) | Thiosaccharide mucolytic agents | |
| DK2860211T3 (da) | Phosphorsyreester-præparater med forringet hygroskopi | |
| CL2017000587A1 (es) | Derivados de tetrahidroquinolina como inhibidores de bromodominio | |
| BR112017007753A2 (pt) | uso de uma composição cosmética que compreende ácido 10-hidroxiesteárico. | |
| LT3419595T (lt) | Stabili skysta gonadotropino kompozicija | |
| SG10202008700VA (en) | α-TRUXILLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF | |
| BR112015006692A2 (pt) | formulação de nanodispersão, método para administrar uma formulação de nanodispersão líquida de taxina livre de etanol em um indivíduo, e, kit. | |
| UY34552A (es) | Forma cristalina delta de la sal de arginina de perindoprilo, su procedimiento de preparación, y las composiciones farmacéuticas que la contienen | |
| DK3369429T3 (da) | Farmaceutisk sammensætning tiltænkt at blive administreret til næseslimhinden | |
| BR112014022687A2 (pt) | Uso de uma quantidade eficaz de r-p88 ou um sal farmaceuticamente aceitável do mesmo, ou um éster do mesmo ou um sal farmaceuticamente aceitável de um éster do mesmo, composição farmacêutica, r-p88 ou um sal farmaceuticamente aceitável do mesmo, ou um éster do mesmo ou um sal farmaceuticamente aceitável de um éster do mesmo | |
| BR112017024126A2 (pt) | composições farmacêuticas e uso das mesmas | |
| GEAP201814463A (en) | Pharmaceutical composition for use in increasing the trophism of nasal mucosa | |
| BR112013027391A2 (pt) | formulação farmacêutica, frasco e kit | |
| IT201700117361A1 (it) | Composizione liquida per uso come antiinfiammatorio | |
| UY35958A (es) | Derivados de quinolina como insecticidas y acaricidas |